Joshua Jennings analyst TD COWEN

Currently out of the existing stock ratings of Joshua Jennings, 316 are a BUY (88.27%), 41 are a HOLD (11.45%), 1 are a SELL (0.28%).

Joshua Jennings

Work Performance Price Targets & Ratings Chart

Analyst Joshua Jennings, currently employed at TD COWEN, carries an average stock price target met ratio of 53.8% that have a potential upside of 31.9% achieved within 235 days.

Joshua Jennings’s has documented 704 price targets and ratings displayed on 38 stocks. The coverage is on the Healthcare sector.

Most recent stock forecast was given on TMDX, TransMedics Group at 01-Jul-2026.

Wall Street Analyst Joshua Jennings

Analyst best performing recommendations are on DCBO (DOCEBO).
The best stock recommendation documented was for HUMA (HUMACYTE) at 6/25/2024. The price target of $7.5 was fulfilled within 20 days with a profit of $2.57 (52.13%) receiving and performance score of 26.06.

Average potential price target upside

ABT Abbott Laboratories BAX Baxter International BSX Boston Scientific Corp ESTA Establishment Labs Holdings EW Edwards Lifesciences Corp GILD Gilead Sciences HUMA Humacyte JNJ Johnson & Johnson MDT Medtronic PLC NUVA NuVasive OM Outset Medical  SYK Stryker TMDX TransMedics Group ZBH Zimmer Biomet Holdings ATEC Alphatec Holdings CERS Cerus APEN Apollo Endosurgery ITMR Itamar Medical Ltd PROF Profound Medical Corp AZYO Aziyo Biologics  QTNT Quotient Ltd TNDM Tandem Diabetes Care DXCM DexCom STXS Stereotaxis MDWD Mediwound Ltd BDX Becton Dickinson and Company BFLY Butterfly Network CTSO Cytosorbents Crp PRCT Procept Biorobotics Corp RBOT Vicarious Surgical DCBO Docebo PODD Insulet VCEL Vericel Corp Ord CBLL CeriBell SENS Senseonics Holdings AVD American Vanguard RCEL Avita Medical Ltd ALUR Allurion Technologies

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 19-Sep-2024

$115

$20.88 (22.18%)

$115

17 days ago
(22-Jun-2026)

2/7 (28.57%)

$27.17 (30.93%)

143

Buy Since 02-Jun-2021

$131

$36.88 (39.18%)

$131

2 months 12 days ago
(27-Apr-2026)

9/21 (42.86%)

$38.2 (41.16%)

559

Buy Since 17-Dec-2018

$143

$48.88 (51.93%)

$144

2 months 19 days ago
(20-Apr-2026)

19/31 (61.29%)

$47 (48.96%)

495

Buy Since 18-Jul-2018

$120

$25.88 (27.50%)

$134

2 months 22 days ago
(17-Apr-2026)

10/18 (55.56%)

$23.19 (23.95%)

290

Buy Since 25-May-2021

$120

$25.88 (27.50%)

$150

2 months 22 days ago
(17-Apr-2026)

1/7 (14.29%)

$23.19 (23.95%)

194

Show more analysts

Please expand the browser size to see the chart

Which stock is Joshua Jennings is most bullish on?

Potential upside of $54.86 has been obtained for BSX (BOSTON SCIENTIFIC CORP)

Which stock is Joshua Jennings is most reserved on?

Potential downside of -$13.04 has been obtained for JNJ (JOHNSON & JOHNSON)

What Year was the first public recommendation made by Joshua Jennings?

On 2013

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?